THE BEST SIDE OF MOUNJARO TIRZEPATIDE 7.5MG INJECTION

The demo accomplished each its Main endpoints, with semaglutide 2.4 mg demonstrating statistically important and excellent improvements in liver fibrosis without any worsening of steatohepatitis, and resolution of steatohepatitis with no worsening of liver fibrosis in individuals with MASH compared to placebo.1Inactive ingredients: sodium chloride,